CompletedNCT04310631
Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab
Studying Coats disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Federico II University
- Principal Investigator
- Gilda CennamoFederico II University
- Intervention
- Ranibizumab Injection(drug)
- Enrollment
- 5 enrolled
- Eligibility
- 19-30 years · MALE
- Timeline
- 2016 – 2019
Study locations (1)
- University of Naples "Federico II", Naples, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04310631 on ClinicalTrials.govOther trials for Coats disease
Additional recruiting or active studies for the same condition.